Myeloablative Conditioning Followed by T-Cell Replete Haploidentical Related Donor Peripheral Blood Stem Cell Transplant Using Post-Transplant Cyclophosphamide Immune Tolerance Approach for High Risk Haematological Malignancies: An Indian Perspective.

Sanket P. Shah; Vivek S. Radhakrishnan; Ganesh S. Jaishetwar; Reghu K. Sukumaran; Mita Roychowdhury; Jeevan Kumar; Saurabh Jayant Bhave; Reena Nair; Mammen Chandy

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Myeloablative Conditioning Followed by T-Cell Replete Haploidentical Related Donor Peripheral Blood Stem Cell Transplant Using Post-Transplant Cyclophosphamide Immune Tolerance Approach for High Risk Haematological Malignancies: An Indian Perspective.

【24h】

Myeloablative Conditioning Followed by T-Cell Replete Haploidentical Related Donor Peripheral Blood Stem Cell Transplant Using Post-Transplant Cyclophosphamide Immune Tolerance Approach for High Risk Haematological Malignancies: An Indian Perspective.

机译：髓鞘调理随后是T细胞新增寄生相关供体外周血血液干细胞移植使用后切对后的环磷酰胺免疫耐受方法进行高危血液恶性肿瘤：印度观点。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2018年第3期|共2页
作者
Sanket P. Shah; Vivek S. Radhakrishnan; Ganesh S. Jaishetwar; Reghu K. Sukumaran; Mita Roychowdhury; Jeevan Kumar; Saurabh Jayant Bhave; Reena Nair; Mammen Chandy;
展开▼
作者单位

Clinical Haematology and Bone Marrow Transplant Tata Medical Center;

Clinical Haematology and Bone Marrow Transplant Tata Medical Center;

Clinical Haematology and Bone Marrow Transplant Yashoda Hospital;

Bone Marrow Transplant Division Aster Medcity;

Clinical Haematology and Bone Marrow Transplant Tata Medical Center;

Clinical Haematology and Bone Marrow Transplant Tata Medical Center;

Clinical Haematology and Bone Marrow Transplant Tata Medical Center;

Clinical Haematology and Bone Marrow Transplant Tata Medical Center;

Clinical Haematology and Bone Marrow Transplant Tata Medical Center;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
专利

1. Myeloablative Conditioning Followed by T-Cell Replete Haploidentical Related Donor Peripheral Blood Stem Cell Transplant Using Post-Transplant Cyclophosphamide Immune Tolerance Approach for High Risk Haematological Malignancies: An Indian Perspective. [J] . Sanket P. Shah, Vivek S. Radhakrishnan, Ganesh S. Jaishetwar, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：髓鞘调理随后是T细胞新增寄生相关供体外周血血液干细胞移植使用后切对后的环磷酰胺免疫耐受方法进行高危血液恶性肿瘤：印度观点。
2. Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial [J] . SolomonS.R., SizemoreC.A., SanacoreM., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2012,第12期

机译：在缺乏常规捐献者的高风险血液恶性肿瘤患者中，使用T细胞充足的外周血干细胞和清髓性条件进行的单倍体移植耐受性好，并能产生优异的无复发生存：II期试验的结果
3. Haploidentical BMT Using Fully Myeloablative Conditioning, T Cell Replete Bone Marrow Grafts, and Post-Transplant Cyclophosphamide (PT/Cy) Has Limited Toxicity and Promising Efficacy in Largest Reported Experience with High Risk Hematologic Malignancies [J] . Symons Heather J., Chen Allen, Gamper Christopher, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：使用完全清髓条件处理，T细胞充足的骨髓移植和移植后环磷酰胺（PT / Cy）的单倍BMT在最大的高风险血液系统恶性肿瘤报道中具有有限的毒性和有希望的疗效
4. Computer Modeling of the Immune System Reconstruction after Peripheral Blood Stem Cell Transplantation [C] . Gergana Bencheva, Lidia Gartcheva, Antoaneta Michova, Mathematical modeling and computational science. . 2011

机译：外周血干细胞移植后免疫系统重建的计算机建模
5. Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide [O] . Asad Bashey, Mei-Jie Zhang, Shannon R. McCurdy, -1

机译：动员的外周血干细胞与未刺激的骨髓作为移植后使用环磷酰胺进行T细胞充足单倍体供体移植的移植来源
6. Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial [O] . Solomon Scott R., Sizemore Connie A., Sanacore Melissa, 2012

机译：在缺乏常规供体的高风险血液恶性肿瘤患者中，使用T细胞充足的外周血干细胞和清髓性条件进行的单倍体移植耐受性良好，并具有良好的无复发生存率：一项预期的II期试验结果

Myeloablative Conditioning Followed by T-Cell Replete Haploidentical Related Donor Peripheral Blood Stem Cell Transplant Using Post-Transplant Cyclophosphamide Immune Tolerance Approach for High Risk Haematological Malignancies: An Indian Perspective.

著录项

相似文献

相关主题

期刊订阅